Literature DB >> 28439133

Importance of Pharmacy Involvement in the Treatment of Sepsis.

Joseph B Cavanaugh, Jesse B Sullivan, Nicole East, Jessica N Nodzon.   

Abstract

Purpose: A review of the impact of pharmacists on appropriate medication selection, timing of administration, and as members of a multidisciplinary sepsis response team. Summary: Early goal-directed therapy (EGDT), currently recommended by the 2013 Surviving Sepsis Campaign guidelines for the management of patients with sepsis, includes the administration of appropriate antibiotics in patients with septic shock within the first hour. Multidisciplinary teams containing pharmacists have been shown to decrease time to antibiotic delivery, time to antibiotic administration, and patient mortality. The pharmacist can act as a drug information resource, expedite the medication verification and procurement process, and offer suggestions on how to better manage the patients. Pharmacists are often consulted for dosing and antibiotic selection recommendations for patients with sepsis, but they can also help increase the appropriateness of antibiotics selected. Additional recommendations and interventions made by pharmacists include fluid management and vasopressor facilitation for the more severe patients. A sepsis management team that included a pharmacist increased the number of patients receiving appropriate antibiotics within the first hour by as much as 22-fold. Another study has demonstrated that intensive care units with a pharmacist are associated with a 4% decrease in sepsis patient mortality compared to those without a pharmacist.
Conclusion: Multidisciplinary teams containing pharmacists have been shown to decrease time to administration of antibiotics, increase appropriate selection of medications, and decrease mortality; they may also decrease overall health care costs.

Entities:  

Keywords:  early goal-directed therapy; multidisciplinary team; pharmacist; sepsis

Year:  2017        PMID: 28439133      PMCID: PMC5396986          DOI: 10.1310/hpj5203-191

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  29 in total

1.  Prospective external validation of the clinical effectiveness of an emergency department-based early goal-directed therapy protocol for severe sepsis and septic shock.

Authors:  Alan E Jones; Anne Focht; James M Horton; Jeffrey A Kline
Journal:  Chest       Date:  2007-06-15       Impact factor: 9.410

2.  Implementation of modified early-goal directed therapy for sepsis in the emergency center of a comprehensive cancer center.

Authors:  Katy M Hanzelka; Sai-Ching J Yeung; Gary Chisholm; Kelly Willis Merriman; Susan Gaeta; Imrana Malik; Terry W Rice
Journal:  Support Care Cancer       Date:  2012-09-07       Impact factor: 3.603

3.  Pharmacist impact on time to antibiotic administration in patients with sepsis in an ED.

Authors:  Kayvan Moussavi; Vitaliy Nikitenko
Journal:  Am J Emerg Med       Date:  2016-07-20       Impact factor: 2.469

4.  Pharmacist's activities on a trauma response team in the emergency department.

Authors:  Asad E Patanwala; Daniel P Hays
Journal:  Am J Health Syst Pharm       Date:  2010-09-15       Impact factor: 2.637

5.  Utilization of Pharmacist Responders as a Component of a Multidisciplinary Sepsis Bundle.

Authors:  Jeremy D Flynn; Kevin W McConeghy; Alexander H Flannery; Melissa Nestor; Pam Branson; Kevin W Hatton
Journal:  Ann Pharmacother       Date:  2014-06-05       Impact factor: 3.154

6.  Emergency medicine pharmacists and sepsis management.

Authors:  Kyle A Weant; Stephanie N Baker
Journal:  J Pharm Pract       Date:  2012-12-02

7.  Timing of appropriate antibiotics in patients with septic shock: a retrospective cohort study.

Authors:  Martin Cullen; Toby Fogg; Anthony Delaney
Journal:  Emerg Med Australas       Date:  2013-07-21       Impact factor: 2.151

8.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

9.  Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department.

Authors:  David F Gaieski; Mark E Mikkelsen; Roger A Band; Jesse M Pines; Richard Massone; Frances F Furia; Frances S Shofer; Munish Goyal
Journal:  Crit Care Med       Date:  2010-04       Impact factor: 7.598

10.  Timing and appropriateness of initial antibiotic therapy in newly presenting septic patients.

Authors:  Antonia L Vilella; Charles F Seifert
Journal:  Am J Emerg Med       Date:  2013-10-17       Impact factor: 2.469

View more
  1 in total

1.  PTX3 Protects Intestinal Mucosal Barrier Damage in Sepsis Through Toll-Like Receptor Signaling Pathway.

Authors:  Jian Li; Yan Li; Ruifeng Chai; Xiangyou Yu; Zhaoxia Yu
Journal:  Inflammation       Date:  2022-06-10       Impact factor: 4.092

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.